The alphavirus capsid protein (CP) is a serine protease that possesses cis-proteolytic activity essential for its release from the nascent structural polyprotein. The released CP further participates in viral genome encapsidation and nucleocapsid core formation, followed by its attachment to glycoproteins and virus budding. Thus, protease activity of the alphavirus capsid is a potential antialphaviral target to arrest capsid release, maturation, and structural polyprotein processing. However, the discovery of capsid protease inhibitors has been hampered due to the lack of a suitable screening assay and of the crystal structure in its active form. Here, we report the development of a trans-proteolytic activity assay for Aura virus capsid protease (AVCP) based on fluorescence resonance energy transfer (FRET) for screening protease inhibitors. Kinetic parameters using fluorogenic peptide substrates were estimated, and the K m value was found to be 2.63 ؎ 0.62 M while the k cat /K m value was 4.97 ؋ 10 4 M ؊1 min ؊1 . Also, the crystal structure of the trans-active form of AVCP has been determined to 1.81-Å resolution. Structural comparisons of the active form with the crystal structures of available substrate-bound mutant and inactive blocked forms of the capsid protease identify conformational changes in the active site, the oxyanion hole, and the substrate specificity pocket residues, which could be critical for rational drug design.
A lphaviruses are arthropod-borne, enveloped, positive-sense, single-stranded RNA viruses that are the causative agents of a range of serious human and livestock diseases. Infection in humans can cause fever, rash, encephalitis, and polyarthritis. The members of genus alphavirus include chikungunya virus (CHIKV), eastern, western, and Venezuelan equine encephalitis virus, Aura virus, Semliki Forest virus (SFV), and Sindbis virus (SINV). Due to the epidemic outbreak of CHIKV in 2005 to 2006 in the Indian subcontinent, it is considered to be a reemerging pathogen and a potential public health threat. Currently, no antiviral drug or vaccine is available against alphaviruses.
The 49S and 26S RNAs of alphaviruses are translated into the nonstructural and structural proteins in the infected cell, respectively. The structural polyproteins are capsid protein (CP), E3, E2, 6K, and E1 (1) . The alphavirus CP is present at the amino terminus of the structural polyprotein and has been reported to be a chymotrypsin-like serine protease. The first step in structural polyprotein processing is the autocatalytic cleavage of CP to release itself from the rest of the polyprotein (2, 3) . This released CP performs multiple functions in the virus life cycle, including the formation of capsomers by intermolecular interactions with other CP monomers, the encapsidation of the genomic RNA to form the nucleocapsid cores, and the interaction with the cytoplasmic domain of glycoproteins that is essential for the virus budding process (4) (5) (6) (7) (8) (9) .
The alphavirus CP consists of two major domains. The N-terminal domain is highly disordered, rich in basic amino acids, and functions during encapsidation of viral genomic RNA (4, (10) (11) (12) . The C-terminal domain possesses cis-autoproteolytic activity and is inactivated after cleavage of the scissile bond between Trp and Ser residues (Aura virus CP [AVCP] residues W267 and S268). The Trp-Ser residues containing the scissile bond are conserved among all alphaviruses and are present at the C-terminal end of CP. After cleavage, the free carboxylic group of conserved Trp267 at the P 1 position interacts with the catalytic triad and remains bound in the S 1 pocket of the CP. This bound carboxyl terminus tryptophan residue in the active site inactivates the protease and blocks further trans-cleavage activity (2, (13) (14) (15) (16) . The active-site molecular architecture and the catalytic triad are well conserved among all serine proteases including alphavirus CPs (AVCP His144, Asp163, and Ser218) and exhibit similar spatial architectures in the active site (2, 16, 17) . Additionally, the GDSG motif containing the active-site nucleophilic serine residue that is well conserved in chymotrypsin-like serine proteases is also found to be completely conserved in the CP of alphaviruses (AVCP 215 GDSG 219 ) (2, 13, 14, 16) .
The CP is reported to lack trans-activity since it is an autoproteolytic enzyme that auto-inhibits to give a turnover number of 1 (2, 17) . However, investigations by Morillas et al. have revealed that truncations of 1 to 7 C-terminal residues of the SFV CP, including deletion of the ultimate C-terminal tryptophan, restores the enzymatic activity of the protein (18) . The truncated enzyme was found to possess high esterase activity after deletion of the highly conserved C-terminal tryptophan. However, until now the trans-cleavage protease activity of the alphavirus CP in which trans-cleavage of the peptide bond with tryptophan at the P 1 position has not been demonstrated. Furthermore, Morillas et al. concluded from the study that correct folding of the tertiary structure of SFV CP is dependent on the presence of a conserved Trp residue at the C terminus (18) . The findings of this study were intriguing and persuaded us to probe the trans-peptidase activity and structure of the precleavage form of another member of alphavirus genus, AVCP.
The crystal structures of the postcleavage form of CP having the C-terminal tryptophan bound in the catalytic site have been reported from different members of the alphavirus genus including Aura virus. Additionally, the crystal structure of catalytically inactive S215A variant of Sindbis virus capsid protein (SCP) is also available, in which two additional C-terminal P 1 = and P 2 = residues (Ser265 and Ala266) are also bound near the active site (13) . As the structure consists of substrate residues in the specificity pocket, this structure is considered an enzyme-substrate complex form of CP in which the catalytic triad residue Ser215 has been mutated to alanine to abolish the self-cleavage activity. Until now, the structures available for the alphavirus CP were of the inactive state with a blocked catalytic site (2, 14, 16, 19) . Therefore, the development of structure-based antiviral drug design strategies targeting the CP proteolytic activity has been lacking due to the unavailability of the structure of the unblocked active enzymatic form and the lack of a CP protease assay.
The C-terminal domain of CP also participates in the budding process by interacting with the glycoproteins through a hydrophobic pocket that lies on the capsid surface (20) . This hydrophobic pocket has also been proposed to be involved in the capsidcapsid interaction required for nucleocapsid formation (21) . The crystal structure of SCP containing a dioxane molecule in the hydrophobic pocket suggested the use of dioxane derivatives for targeting the interaction of the capsid and E2 glycoprotein for antiviral development (22) . Some dioxane derivatives that prevent CP-glycoprotein interaction by binding to the CP hydrophobic pocket lead to defects in virus budding (23, 24) . However, specific antiviral molecules that target the capsid protease activity and block the initiation of polyprotein processing have not yet been identified.
In this study, the structural analysis of the C-terminally truncated protease domain from Aura virus (AVCP⌬2, AVCP with a deletion of the last two residues at the C terminus) is described, and a biochemical analysis of the trans-protease activity of the protein is reported. The high-resolution atomic structure of AVCP⌬2, which represents the unblocked catalytically active form of enzyme, has been determined. This is the first report of the trans-proteolytic activity and the crystal structure of the active form of the alphavirus CP. We discuss the conformational changes in the protein catalytic site, the oxyanion hole, and the substrate specificity pockets upon transition from catalytically active to fully processed and cleaved (subsequent to auto-catalytic cleavage) inactive protein via a substrate-bound complex intermediate. The observation provides insight into the properly folded structure of the trans-active form and new possibilities for structure-based antiviral drug design targeting the protease activity of alphavirus CP.
MATERIALS AND METHODS
Construction of expression plasmid. The AVCP⌬2 construct (residues 110 to 265) was prepared in which the N-terminal disordered region and the last two residues at the C terminus of the protease domain were deleted. Aura virus genomic cDNA was used as the template for PCR amplification of the DNA fragments encoding AVCP⌬2. The oligonucleotides 5=-CTGGAATT CATATGGCCCTGAAATTTGAAGCCGAC-3= (forward) and 5=-CTAG AATCTCGAGCTATACAGTATCTTCGTGGGTGG-3= (reverse) containing NdeI and XhoI sites, respectively, were used in the PCR. These primers were designed on the basis of GenBank accession number NP_819015.1. The PCR-amplified DNA fragment was purified using a PCR purification kit (Qiagen, USA) according to the manufacturer's instructions. The purified PCR fragment and pET28c vector containing the tobacco etch virus (TEV) protease cleavage site were digested with NdeI and XhoI restriction enzymes. The digested products were separated on a 1% agarose gel and purified using a DNA gel extraction kit (Qiagen, USA). Restriction enzyme-digested plasmid and PCR products were ligated using T4 DNA ligase. DH5␣(DE3) cells were transformed with the ligation mixture by the heat shock method (25) . The transformed cells were plated on Luria-Bertani (LB) agar plates containing 50 g/ml kanamycin and incubated overnight at 37°C. The obtained colonies were picked and grown overnight at 37°C in LB broth containing 50 g/ml of kanamycin. Plasmids isolated from a 5-ml culture using a MiniPrep plasmid isolation kit (Qiagen, USA) were screened by PCR and assayed by restriction enzyme digestion for the presence of the AVCP⌬2 insert. This insert was sequenced in both directions using T7 forward and T7 reverse primers to confirm the identity of the pET28c-AVCP⌬2 plasmid. Expression and purification of AVCP⌬2. For protein production, the cloned recombinant pET28c-AVCP⌬2 plasmid was transformed into Escherichia coli strain Rosetta (DE3). Colonies of the transformed cells were grown in LB broth supplemented with kanamycin (50 g/ml) and chloramphenicol (35 g/ml) at 37°C to an optical density of 0.4 at 600 nm (OD 600 ). At this point, the temperature was reduced to 18°C, and the culture was allowed to grow to an OD 600 of 0.8. Protein expression was then induced using 0.4 mM isopropyl ␤-D-1-thiogalactopyranoside (IPTG), and the induced culture was grown overnight at 18°C. The cells were harvested by centrifugation, and the obtained cell pellet was stored at Ϫ80°C until further use.
The purification procedure for AVCP⌬2 was very similar to the published protocol for the native AVCP (26) . Briefly, the cell pellet from a 1-liter culture was resuspended on ice in 30 ml of purification buffer (50 mM Tris-HCl, pH 7.6, 15 mM imidazole, and 100 mM NaCl), and the cells were disrupted using a cell disruptor (Constant Systems, Ltd., Daventry, England). The cell lysate was subjected to centrifugation at 4°C. The N-terminal His-tagged AVCP⌬2 was purified using Ni-nitrilotriacetic acid (NTA) beads (Qiagen, USA), and elution was done in 250 mM imidazole. The N-terminal His tag from AVCP⌬2 was cleaved by incubating the purified protein with TEV protease overnight, and the sample was simultaneously dialyzed against the dialysis buffer (50 mM Tris-HCl, pH 7.6, 20 mM NaCl) at 4°C. After His tag cleavage, the protein sample was reloaded onto a Ni-NTA column to remove His-tagged TEV protease and uncleaved His-tagged AVCP⌬2. The flowthrough containing AVCP⌬2 protein without the His tag was concentrated and loaded onto a preequilibrated HiLoad Superdex 75 16/60 size exclusion chromatography column (GE Healthcare) using an ÄKTA purifier (GE Healthcare), which was operated at a flow rate of 0.5 ml/min at 4°C. Gel filtration fractions were run on a 15% SDS-PAGE gel to analyze protein purity. The fractions containing pure protein were pooled and concentrated to 15 mg/ml using a 3-kDa-cutoff Amicon Ultra-15 concentrator (Millipore, Bedford, MA, USA). The concentration and yield of purified protein were estimated by UV-visible light (Vis) spectroscopy at 280 nm using an extinction coefficient method. The yield of AVCP⌬2 from 1 liter of bacterial culture was ϳ15 mg, which is slightly higher than that of the native AVCP (26) .
trans-Protease activity assay. The proteolytic activity assay for AVCP⌬2 was performed by a fluorescence resonance energy transfer (FRET)-based proteolytic assay using 5-[(2=-aminoethyl)-amino] naphthelenesulfonic acid (EDANS) and 4-[[4-(dimethylamino)phenyl]-azo] benzoic acid (DABCYL) as the FRET pair. The peptide having DABCYL and EDANS at the N and C termini, respectively, was procured from Biolinkk, New Delhi, India. The sequence of the substrate peptide was derived from the cleavage site of CP containing the conserved Trp-Ser scissile bond for protease cleavage. The cleavage analysis was performed in 20 mM HEPES buffer (pH 7.0) (reaction buffer) at room temperature. The purified AVCP⌬2 was incubated with the reaction buffer, and the fluorogenic peptide substrate was added to a final concentration of 1 M. The reaction was carried out in total volume of 1 ml in an Eppendorf tube. At various time points, the reaction mixture was transferred to the fluorescence cuvette for steady-state fluorescence measurements with a Fluorolog-3 Spectrofluorimeter LS55 (Horiba/Jobin Yvon/Spex). The fluorogenic peptide substrate was excited at a wavelength of 340 nm, and the emission spectrum scanning from 440 to 600 nm was recorded. The increase in fluorescence was monitored at specific time intervals. For kinetic studies, different peptide substrate concentrations ranging from 0.6 to 16 M were used. The initial velocity (V i ) at different substrate concentrations was calculated. The kinetic parameters were calculated by Lineweaver-Burk plots.
Far-UV CD spectrum. To estimate the secondary structure of AVCP⌬2, circular dichroism (CD) analysis of the purified protein was performed using a computer-controlled Applied Photophysics (model Chirascan; United Kingdom) spectropolarimeter. CD spectra were recorded in a quartz cell of 1 mm at a bandwidth of 1.0 nm between 180 and 260 nm with a time per point of 0.25 s at 25°C. The instrument was subjected to constant nitrogen purge. The CD experiment was performed using 0.1 mg/ml of purified protein in 20 mM potassium phosphate buffer at pH 7.5. Three scans were recorded and averaged. The baseline for the blank buffer was subtracted from the average protein spectrum, and the secondary structure was determined by the online server Dichroweb using the CONTIN method (27) .
Crystallization and data collection. Purified and concentrated protein was crystallized using the sitting-drop vapor diffusion method. Protein crystallization was done in a 96-well sitting-drop crystallization tray (Hampton Research, Aliso Viejo, CA) with 1 l of protein (15 mg/ml in 50 mM Tris-HCl, pH 7.6, 20 mM NaCl), and 1 l of the reservoir solution was equilibrated against 50 l of the reservoir buffer. AVCP⌬2 crystals were obtained in 5 days using 0.2 M sodium citrate tribasic dihydrate and 20% (wt/vol) polyethylene glycol (PEG) 3350 at 20°C. The composition of cryoprotectants was also optimized for high-resolution data collection. Prior to data collection, the obtained crystal was soaked in mother liquor containing 15% (vol/vol) glycerol as a cryoprotectant. X-ray data were collected using an MAR 345 imaging-plate system with Cu K␣ radiation generated by a Bruker-Nonius Microstar H rotating-anode generator operated at 45 kV and 60 mA. The data were collected under cryogenic conditions at a wavelength of 1.54 Å. Diffraction data were processed and scaled using the MOSFLM package (28) . The data collection and processing statistics are summarized in Table 1 .
Structure solution and refinement. The structure determination was carried out using the molecular replacement method by taking the crystal structure of the native AVCP that has the C-terminal tryptophan residue bound to the active site as the search model (Protein Data Bank [PDB] accession number 4AGK). For this purpose, the MOLREP program from the CCP4 software suite was used, and the Refmac5 program was used for the restrained refinement (29, 30) . The analysis of the electron density map and manual model building were carried out using the COOT program (31) . The stereochemical properties of the refined structure model of AVCP⌬2 were analyzed using the PROCHECK program (32) . Structural analysis of the refined model and the preparation of figures were done using the PyMOL visualization tool (33) . For the analysis of dimer interface contacts, the PISA (Protein Interfaces, Surfaces and Assemblies) web server was used (34) .
Protein structure accession number. Structure coordinates for AVCP⌬2 have been deposited in the Protein Data Bank under accession number 4UON.
RESULTS
Purification of active AVCP⌬2. The carboxyl-terminal Trp267 of AVCP remains bound to the S 1 specificity pocket, blocking the entry of substrate for trans-cleavage (16) . This blocked enzyme represents the postcleavage form of CP. Deletion of the conserved Trp267 is anticipated to free the blocked active site, making it 
, where I i (hkl) is the ith observation of reflection hkl and [I(hkl)] is the weighted average intensity for all observations i of reflection hkl.
accessible to the peptide substrate for trans-protease cleavage (Fig.  1A) . This trans-active protease would represent the precleavage state of auto-proteolytic alphavirus CP. Therefore, the AVCP⌬2 (residues 110 to 265) construct with deletion of the C-terminal Glu266 and Trp267 residues from the AVCP domain (residues 110 to 267) was designed and cloned in a bacterial expression vector. The recombinant AVCP⌬2 protein having a TEV protease-removable His 6 affinity tag at the N terminus was produced in soluble form in E. coli. Protein from the soluble fraction was purified using Ni ϩ2 affinity and size exclusion chromatography. The N-terminal His 6 tag was removed from the purified protein using TEV protease. SDS-PAGE analysis showed the presence of a single protein band of ϳ17 kDa, confirming sample purity and homogeneity of the purified AVCP⌬2 (Fig. 1B) . A standard curve using gel filtration molecular-weight markers was prepared, and the average molecular mass of the major elution peak of purified protein was calculated using the calibration curve. The estimated molecular mass of the protein was calculated to be ϳ17 kDa, suggesting that AVCP⌬2 is a monomer in solution.
Characterization of trans-protease activity. For assessment of the trans-protease activity of AVCP⌬2, the fluorogenic peptide substrate DABCYL-Gly-Ala-Glu-Glu-Trp2Ser-Leu-Ala-Ile-Glu-EDANS (where the down arrow indicates cleavage between the conserved Trp and Ser residues, in boldface) was used. In this fluorometric assay, EDANS is the fluorophore donor, having an excitation wavelength at 340 nm and a maximum emission wavelength at 490 nm. DABCYL is the nonfluorescent quencher, having a maximum absorption at a 470-to 520-nm wavelength. The activity of AVCP⌬2 was measured by FRET analysis at different time points. The donor fluorophore EDANS was excited at 340 nm, and emission spectra were recorded by scanning from 440 to 600 nm. To perform this experiment, a fixed concentration of substrate (1 M) was used, and the fluorescence data measurements were made at specific time intervals. An increase in the intensity of fluorescence with time corresponds to a decrease in the FRET signal, which demonstrates the cleavage of the peptide substrate (Fig. 1C) . The effect of pH on the trans-protease activity of AVCP⌬2 was determined by performing the fluorometric protease assay in the pH range of 4.5 to 9.5. The pH optimal for the peptide substrate DABCYL-GAEEW2SLAIE-EDANS was 7.0 (data not shown). To determine the kinetic parameters, the calculated V i was plotted against different substrate concentrations (Fig. 1D) . A Lineweaver-Burk plot was used to determine the value of K m for the given fluorogenic peptide substrate. The value of K m was found to be 2.63 Ϯ 0.62 M, and the value for catalytic efficiency, k cat /K m , for the AVCP⌬2 trans-protease activity was found to be 4.97 ϫ 10 4 M Ϫ1 min
Ϫ1
. The purified inactive form of AVCP containing Trp267 at the C terminus that blocks the active form Trp267 shows auto-inhibitory action on enzyme activity after autoproteolysis (left). In the absence of Trp267, the protein acquires its catalytic property as the substrate can easily access the active site (right). (B) Gel filtration chromatography and SDS-PAGE analysis of major peak fractions show the protein (AVCP⌬2) purified to homogeneity. The protein is monomeric in nature, as determined by the gel filtration profile. AU, arbitrary units. (C) Analysis of in vitro trans-proteolytic activity of AVCP⌬2. The enzymatic cleavage assay was carried out using 15 g of protein in HEPES buffer (20 mM, pH 7.0) by the addition of 1 M fluorogenic peptide substrate at room temperature. The hydrolysis of the peptide substrate was measured at different time intervals. The excitation was done at 340 nm, and the emission spectrum for each time point is shown as a scan from 450 nm to 600 nm. (D) The initial velocity (M/min) was calculated for increasing concentrations of the substrate. Different substrate (S) concentrations ranging from 0.6 M to 16 M were used (x axis). The experiment was done in triplicate, and the values represent the average data. All the data were normalized using the same reaction mixture without the enzyme.
site was used as a negative control in all of the experiments and showed a negligible increase in fluorescence intensity over time (data not shown).
Secondary structure analysis using CD. The far-UV CD spectrum was used to determine the secondary structure content in the purified AVCP⌬2. The analysis of the CD data was performed using the CONTIN method on the Dichroweb web server. The deconvolution of data for AVCP⌬2 indicates a structural content of 2.6% ␣-helix, 40.5% ␤-sheet, 19.2% ␤-turn, and 37.6% random coil (data not shown). For comparative structural analysis, the CD data of native AVCP were also analyzed. The result was comparable to the secondary structure of native AVCP, which shows 2.8% ␣-helix, 42.1% ␤-sheet, 19.1% ␤-turn, and 36% random coil (data not shown). These results suggest that active AVCP⌬2 has an appropriate secondary structure which is similar to that of native AVCP. Thus, it was expected that AVCP⌬2 possessing trans-capsid protease activity would have a tertiary fold very similar to that of the inactive, postcleavage state of AVCP.
Crystallization of AVCP⌬2. To determine the tertiary structure of AVCP⌬2, the purified protein was concentrated to ϳ15 mg/ml, and crystallization attempts were made. Diffraction-quality crystals were obtained by using 0.2 M sodium citrate tribasic dihydrate and 20% (wt/vol) polyethylene glycol 3350 at 20°C. From a single crystal, a complete data set was collected at 1.81 Å (Table 1) . AVCP⌬2 crystals belong to a monoclinic lattice with space group P2 1 ; however, inactive AVCP crystals reported earlier also belonged to the monoclinic lattice but in space group C2 (16) . Two molecules per asymmetric unit are found in AVCP⌬2, whereas inactive AVCP has one monomer per asymmetric unit. The estimated Matthews coefficient was 3.15 Å 3 Da Ϫ1 , and solvent content was 60.97% for two molecules of AVCP⌬2 per asymmetric unit.
Overall structure of AVCP⌬2. The structure of AVCP⌬2 was determined at 1.81-Å resolution and refined to a final R factor of 18.5% and R free of 21.8% with more than 95% residues in the most-favored region of the Ramachandran plot. High-resolution data show clear electron density for the N-terminal six residues, which were disordered and thus not visible in the native AVCP crystal structure (16) . Similar to the other already known chymotrypsin-like serine proteases, the structure of each monomer of AVCP⌬2 consists of two subdomains, with each domain made up of a 6-to 7-stranded, antiparallel, ␤-barrel structure, as shown in Fig. 2A . The catalytic triad consisting of residues His144, Asp166, and Ser218 is placed at the interface of these two domains. The surface view of the monomer depicting different specificity pockets, the oxyanion hole, and the active site is shown in Fig. 2B . The overall fold within each monomer of AVCP⌬2 is very similar to that of the native AVCP, with a root mean square deviation (RMSD) of 0.33 Å on C␣ atoms. On the other hand, comparison of the native AVCP with the native AVCP with bound dioxane in the E2 binding hydrophobic pocket showed an RMSD of 0.13 Å (16). This indicates that the main-chain conformational variations are more pronounced between the native and active forms than the two forms (apo and ligand-bound) of the native AVCP.
At the C terminus of AVCP⌬2, the electron density for the last four residues (262 to 265) is missing, which indicates conformational flexibility of these residues in the absence of the last two residues (Fig. 2C) . In native AVCP, the C-terminal loop takes a ␤ turn at residue His261 to allow Trp267 to bind the substrate specificity pocket. In AVCP⌬2, Trp267 is truncated, so the loop movement is flexible and no longer restricted due to the binding of Trp267 at the S 1 specificity pocket. The movement and flexibility of the loop are crucial for proper positioning of the scissile peptide bond relative to the active site and oxyanion hole for cleavage. Thus, this loop movement toward the active site seems to play an important role in the binding of Trp267 to the active site and the auto-proteolytic property of CP. Moreover, the C-terminal loop, which is missing from the unblocked form and found in the Trpbound native state, shows different conformations in two chains of the SCP substrate-bound intermediate form (Fig. 2C) (13) . This suggests that the loop is highly flexible in three different enzymatic states and becomes restrained in position after proteolytic cleavage.
In the structure of AVCP⌬2, the active form of the enzyme, three glycerol molecules (used as cryoprotectant) are clearly visible in the electron density map of both chains and show interactions with different amino acid residues. Superposition of the crystal structure of AVCP the inactive state and the AVCP⌬2 active form shows that a glycerol molecule binds exactly at the same position where Trp267 is present in the S 1 specificity pocket of AVCP. Another glycerol molecule in both chains of AVCP⌬2 occupies a cavity by making polar interactions with the main chain of Gly147 and Ile149, the side chain of Glu168, and two water molecules. Gly214 in chain A and Tyr131, His196, Asp217, and Arg220 in chain B interact with the third glycerol molecule through H bonding. Since glycerol has been proven to be a protein structure-stabilizing agent, glycerol used in soaking the crystal before cryo-freezing and data collection might be influencing the structure of AVCP⌬2 through stabilization (35) (36) (37) (38) .
Dimeric interactions. This study shows the monomeric nature of the protein in solution and the crystallographic dimer in the asymmetric unit. In the AVCP⌬2 structure, both of the monomers are in tail-to-tail contact through their C-terminal subdomains. Previously, a number of dimers and trimers were found in the SCP and the SFV CPs that were arranged in head-to-tail and tail-to-tail fashion in different crystal forms (2, 13, 19) . In headto-tail dimers, the N-and C-terminal subdomains are in contact, as in the SCP S215A mutant crystal structure (13) . In head-tohead dimer formation, the N-terminal subdomains are in contact, as in the SFV CP wild-type I crystal type (19) .
The dimeric interface area in AVCP⌬2 as calculated using the PISA web server was found to be ϳ375 Å 2 , comprising approximately 4.5% of the total solvent-accessible area for each monomer, which was consistent with previous reports in SCP (13, 14) . The dimer interaction involves two sheets, VII and VIII ( 190 GFYNW 194 and 197 GAVQFS 202 ) and two loops ( 188 PE 189 and 224 DNS 226 ) of both the monomers. The two chains are held together by a few hydrogen bonds and mostly nonbonded interactions (13, 19) .
These contacts are facilitated by the contribution of 11 residues from each subunit that are common to both of the monomers. The residues Pro188, Glu189, Gly190, Phe191, Tyr192, Asn193, Gly197, Ala198, Asp224, Asn225, and Ser226 from both monomers comprise the dimer interface. These mainly involve hydrophobic interactions along with hydrogen bond formation by residue Asn225 of one monomer with Phe191 and Tyr192 residues of the other monomer (Fig. 2D) . The hydrophobic interactions were found to play a more important role in dimer formation than the hydrogen bonding. However, no evidence is available for the biological relevance of this dimer. Moreover, the mutations that lead to crystallographic dimer disruption show no adverse effect on viral replication (13) . Thus, two molecules in the asymmetric unit do not represent a physiological dimer, and this is consistent with the AVCP being a monomer in solution.
Conformational switching in the hydrophobic pocket. The electron density corresponding to the N-terminal residues from 110 to 115 (plus two extra residues at the N-terminal left after His tag cleavage) is present in both chains of the AVCP⌬2 structure. These residues were disordered in the previously reported inactive AVCP and in the dioxane-bound AVCP structures (16) . These residues in AVCP⌬2 form an arm that projects out of the structure. A detailed analysis of the AVCP⌬2 structure shows that this N-terminal arm interacts and binds in the hydrophobic pocket which is formed between the two ␤-barrel subdomains of the neighboring symmetry monomer molecule (Fig. 3A and B) . The hydrophobic residues Leu111 and Phe113 of the N-terminal arm bind at the pocket between Tyr183, Trp250, and Phe169. Other residues that line this cavity are Met135, Glu136, Lys138, Ser162, and Met167. Figure 3C shows various interactions that stabilize the binding of the N-terminal arm in this pocket. Earlier crystallographic reports of the alphavirus capsid have also reported that this hydrophobic pocket is occupied by similar binding of the hydrophobic N-terminal arm residues from neighboring CP molecules (13, 21) .
Based on structural and mutational studies, it is hypothesized that this hydrophobic pocket plays a role at two stages in the virus life cycle. First, the binding of the N-terminal arm residues to the hydrophobic pocket in crystal structures of two different alphaviruses, including AVCP⌬2 and SCP, suggests that this interaction has biological significance (13, 21) . Furthermore, mutational studies of capsid residues 108 and 110 in the SCP have revealed the role of this interaction in capsid assembly (21) . Thus, it is proposed that binding of the N-terminal arm in the hydrophobic pocket of neighboring CP contributes to the formation of nucleo- capsid core by linking capsid proteins together before RNA binding and core assembly. Additionally, sequence analogy of cytoplasmic domain of E2 (cdE2) and the N-terminal arm of CP and mutational, modeling, and structural studies have suggested that cdE2 and CP hydrophobic pocket interactions are crucial for the virus budding process (16, 20, 22) . A conformational switching in the hydrophobic pocket has been proposed that changes the role of this pocket from core assembly to virus budding (19) .
The structural comparison of the hydrophobic pocket in the precleavage state, AVCP⌬2 (with bound N-terminal arm), and the postcleavage state, AVCP (with unoccupied hydrophobic pocket), visibly illustrates conformational changes in the hydrophobic pocket (Fig. 4A) . It is presumed that the slightly wider pocket with the bound N-terminal arm in AVCP⌬2 represents the conformation likely to promote core assembly, whereas the narrower pocket with two somewhat distinct subpockets in the inactive AVCP is perhaps engaged in interaction with cdE2, which is desirable for virus budding. As shown in Fig. 4B , minor variations in most of the side chains of residues (Glu136, Met135, Lys138, Ser162, Met167, and Phe169) lining the hydrophobic pocket direct this conformational variation. However, further investigations are required to confirm this presumption of conformational switching in the hydrophobic pocket.
The catalytic triad. The alphavirus CP has a fold similar to the folds of the chymotrypsin-like serine proteases, and the conserved catalytic triad residues Ser218, His144, and Asp166 of AVCP form the active site at the interface between the two ␤-barrel subdomains ( Fig. 2A) (2, 13, 14, 16, 19) . The polar interactions of Ser218 and His144 with Trp267 and the complementary shape of the S 1 specificity pocket and side chain of Trp267 likely fix the position of the completely conserved P 1 residue Trp267 in the active site for scissile bond cleavage. In both chains of the AVCP⌬2 structure, which represents the precleavage state, Ser218 is found to be present in two alternate conformations, showing its flexibility, and gets fixed upon entry of the substrate (Fig. 5A) . However, in the postcleavage state, represented by AVCP, Ser218 does not show flexibility as the carboxyl-terminal Trp267 produced on scissile bond cleavage makes polar contacts with the Ser218 side chain (16) . The Ser218 main chain shows displacement of only 0.4 Å between the active precleavage and the inactive postcleavage states. His144 and Asp166 show similar polar interactions with each other and with no alternate conformations in various enzymatic states. Only a minor difference of 0.4 to 0.6 Å is detectable in the side chain of His144. The Asp166 residue is partially exposed to the solvent and interacts with two conserved water molecules in both enzymatic forms. 
FIG 4 Structural comparison of the hydrophobic pockets between native and
active forms of AVCP. The surface view (A) and the superposed view of the hydrophobic pocket of the active AVCP⌬2 (green) over the inactive AVCP (pink) crystal structure (B), which shows the differences in the side-chain conformation of some of the residues that occur at this hydrophobic pocket to accommodate the N-terminal arm of the neighboring subunit.
The oxyanion hole. The oxyanion hole, indispensable for proteolytic activity, plays a role in the substrate binding and stabilization of the tetrahedral transition intermediate containing the oxyanion through polar interactions with the main-chain amides of the conserved GDSG motif (39, 40) . Interestingly, the crystal structure of AVCP⌬2 shows altered conformation of its oxyanion hole (Fig. 2C) . This has resulted due to a flip of the peptide bond between Pro215 and Gly216, as shown by Fig. 5B . The oxyanion hole residues Gly216 and Gly219 show backbone conformational differences in both structure forms. A displacement of up to 2.9 Å can be observed in the region of residues Gly213 to Gly216, as shown in Fig. 5B . Thus, these conformational changes reveal the role of the oxyanion hole main chain in substrate binding. The Ser218 residue conformational change does not have any effect on the alteration of the oxyanion hole conformation as can be seen from the mutant S215A crystal structure of SCP and an equivalent substitution in subtilisin (13, 41) . Superposition of crystal structures of AVCP⌬2, the active precleavage state, and AVCP, the inactive postcleavage state, shows that the carboxylate oxygen atom of Trp267 in AVCP is just 1.9 Å away from the carboxyl oxygen of Pro215 in AVCP⌬2, indicative of steric hindrance in substrate binding. These conformational changes in residues Gly213 to Gly217 change the overall geometry of the specificity pocket, as shown in the surface view in Fig. 5C . Hence, it can be hypothesized that the region of residues 213 to 217 has an altered conformation in the absence of substrate in the specificity pocket of the precleaved state and changes during substrate binding to prevent the steric hindrance between Pro215 and the incoming substrate.
The active form, AVCP⌬2, contains a water molecule in the oxyanion hole (Fig. 6A) . Interestingly, this water molecule is conserved in chain A of the SCP substrate-bound mutant S215A, which is considered an intermediate form (Fig. 6B) , whereas in chain B, the Gly213 (corresponding to Gly216 in AVCP) mainchain NH atom forms an H bond with the carbonyl oxygen atom preceding the scissile bond (Fig. 6C) . This interaction was absent in chain A of the SCP substrate-bound mutant S215A as the loop that brings the substrate inside the substrate binding pocket is highly flexible and does not reach the oxyanion hole in chain A. Postcleavage AVCP also does not contain water molecules in the oxyanion hole and shows similar interactions with the C-terminal carboxylate as chain B of the SCP substrate-bound form (Fig. 6D) . Previously, chain A of the substrate-bound form in SCP was considered an early enzymatic state in which substrate is loosely bound and is more similar to chymotrypsin without substrate (13) . Hence, the unblocked active AVCP⌬2 represents the precleavage state of the alphavirus CP prior to cis-catalytic activity. Consequently, it can be concluded that the substrate scissile bond replaces a water molecule present in the oxyanion hole of AVCP⌬2 during proteolysis.
The substrate specificity pockets. For comparative structural analysis, the structure of AVCP⌬2 was superimposed onto the inactive AVCP as well as onto the substrate-bound SCP mutant S215A structures. A series of conformational changes to variable extents in different specificity pockets are revealed. As seen in the substratebound SCP crystal structure, the substrate specificity pockets S 1 , S 4 , S 1 =, S 2 =, and S 4 = make molecular contacts with the bound substrate residues: Trp264 with the P 1 residue, Thr261 with the P 4 residue, Ser265 with the P 1 = residue, Ala266 with the P 2 = residue, and Pro268 with the P 4 = residue (13) . Inspection of these substrate specificity pockets in the AVCP crystal structure indicates significant conformational changes in the main-chain backbone and also in the side chain of substrate binding residues (Fig. 7) .
The most notable conformational changes are seen both in the backbone and amino acid side chains of the S 1 specificity pocket. The S 1 specificity pocket includes residues Trp194, Ile208 to Ser218 (includes the active-site Ser residue), Ile232 to Asn238, and Thr243 to Leu245. The largest deviation between the active AVCP⌬2 and inactive AVCP is in the main-chain of residues Ile208 to Gly216. The substrate-bound SCP S215A mutant representing the intermediate form shows a conformation rather similar to that of the C-terminal Trp bound inactive AVCP state. This confirms the conformational flexibility of the specificity pocket between active and inactive Trp-bound forms. Gly213 and Gly214 show deviation up to 2.9 Å between AVCP and chain A of active AVCP⌬2. The deviation is different between the two chains and found to be 3.4 Å between AVCP and chain B of AVCP⌬2 (Fig. 2C  and 7A ). Moreover, as described above, Pro215 and Ser218 show side-chain conformational flexibility in the active and inactive forms of AVCP.
Apart from some minor deviations found at the region of res- idues Ile232 to Gly236 among the two structural forms, a displacement of up to 0.9 Å in the main chain can be seen at Ala237 to Thr243. This displacement may be significant as this region lines the substrate specificity pocket. This difference can be accounted for by the presence of the C-terminal residues in AVCP native structure. Due to the presence of Trp in the AVCP crystal structure bound at the S 1 specificity pocket, the C-terminal residues are restricted, and their interaction with neighboring residues forms a compact cavity. In AVCP⌬2, these interactions are absent, and the C-terminal loop is flexible and does not involve such interactions. This suggests a flexible S 1 specificity pocket in the absence of Trp267. The S 1 specificity pocket residue Leu234 in AVCP is conserved among alphavirus CPs. Leu234 main-chain carbonyl O forms an H bond with Ser218 side chains in all of the different forms of the CP. This also forms an H bond with the NH atom of the main chain preceding Trp267 (Fig. 7B) . This suggests the importance of Leu234 in holding the catalytic triad at a proper position and providing a favorable connection between the active site and substrate. The Leu234 backbone shows deviation of less than 0.4 Å between the truncated and native states of AVCP, which could be due to the absence of Trp267 as it interacts with Leu234. Ser214 (conserved in other serine proteases), which corresponds to Leu234 in alphavirus CP, is very crucial for serine protease activity as it forms an H bond with the catalytic triad residue Asp102 (chymotrypsin residue). Also, mutational studies show a reduction in catalytic activity upon Ser214 mutation as the consequence of displacement of its backbone (42) . Thus, the position at Leu234 is very important for substrate binding and hence crucial for catalysis.
Another region of substantial flexibility lies in the S 4 specificity pocket that comprises Ala237, Ser246, and His261 residues, among which Ala237 shows a backbone deviation of 0.6 Å while Ser246 shows side-chain flexibility. In both forms, Ser246 is present in a dual conformation that contributes the major region of flexibility (Fig. 7C) . This Ser246 side chain shows polar contacts with Leu234, Gly235, Val247, Thr259, and Thr264 in both inactive and active AVCP; one additional interaction with His261 is present in inactive form and is absent in the active AVCP⌬2. His261 also shows deviation in the main-chain backbone (0.8 Å) between the two forms of AVCP. It is probably due to the change in His261 position between different enzymatic states to bring the scissile bond near the active site. The P 2 and P 3 residues Glu266 and Val265 are present in a loop which is oriented outwards. Glu266 forms an ionic interaction with catalytic triad residue His144. However, in the active AVCP⌬2 crystal structure, Val265 is found to be disordered.
Similarly, the S 1 = pocket (including residues Met129, His144, and Val145) does not show much variation (ϳ0.4 Å) in the backbone conformation. Ser265, the P 1 = residue in the SCP substratebound form, shows H bonding with Ile126, which corresponds to Met129 in AVCP. Met129 shows polar interaction with the main chain of Val121. Again, the significant variations lie in the S 4 = and S 2 = specificity pockets. The S 4 = pocket residues Asn123 and Lys127 are displaced from the position by 0.5 Å and 0.9 Å, respectively. This pocket consists of Asn120 and Asp124 in SCP; however, the P 4 = residue is hydrophobic in both (Ile271 in AVCP and Pro268 in SCP). Ile128 and Met129 residues in the S 2 = pocket show significant deviation of 0.6 Å and 0.4 Å, respectively (Fig. 7D) . The P 2 = residue Ala266 in the SCP substrate-bound form shows interaction with water molecules.
DISCUSSION
In last 2 decades extensive investigation of the alphavirus CP has been performed. Most of the structure-function analyses have focused on characterization of the inactive form of CP (C-terminal Trp-bound form) using X-ray crystallographic, cryo-electron microscopy, mutational, and biochemical studies (43) (44) (45) . In 2008, the enzymatic characterization of the esterase activity of the truncated form of SFV CP was reported (18) . Up until now, no study has reported in vitro trans-protease activity of the alphavirus CP. It was proposed that the conserved Trp residue at the C terminus is required for proper folding and stabilization of CP. It was moreover proposed that the active capsid produced by truncating the conserved C-terminal Trp is natively an unfolded protein. As a result, the three-dimensional structure of the active form of CP has not been determined.
As a consequence, the protease activity of alphavirus CP has not been targeted for antiviral drug discovery. In this study, a recombinant active AVCP in which two C-terminal P 2 and P 1 residues, Glu266 and Trp267, have been removed (AVCP⌬2) was produced and purified. Purified protein was further used for characterization of the trans-protease activity. A fluorometric assay was developed for screening of protease inhibitors against alphavirus capsid protease. The kinetic studies showed a k cat /K m value of 4.97 ϫ 10 4 M Ϫ1 min Ϫ1 for the trans-protease activity of AVCP⌬2. This result indicates that the protease domain of truncated CP is fully active and possesses catalytic properties similar to other chymotrypsin-like serine proteases.
The crystal structure of this active form of the Aura virus CP (AVCP⌬2) has been determined. This is the active precleavage state preceding cis-catalytic activity. Thus, there are three different forms of the alphavirus CP: the active state (this work), the substrate-bound intermediate form (13) , and the inactive C-terminal Trp-bound form (16) . It is likely that the protein undergoes conformational rearrangements during structural polyprotein processing, viral replication, and budding. The significant conformational changes in the three different forms have been analyzed and reported in this study. The novel structure of the trans-active form of AVCP⌬2 provides structural insight into the catalytic site and substrate binding pockets, revealing a range of conformational flexibilities. Theses conformational variations should be taken into account for structure-based drug designing of anti-alphaviral molecules targeting CP activity.
Additionally, conformational rearrangements are observed by comparison of the precleavage and the postcleavage states of AVCP in the CP hydrophobic pocket (20, 21) . The conformational changes may be responsible for the switching mechanism of the hydrophobic pocket in binding to the N-terminal arm for core assembly and then its interaction with cdE2 glycoprotein during virus budding.
Structural comparisons show that the specificity site pockets are highly flexible. The active-site residue Ser218 side chain is in a dynamic state and exhibits different conformations. The Leu234 backbone has an important role in substrate binding and maintaining the position of the catalytic triad. The oxyanion hole contains a water molecule in the truncated form and chain A of the substrate-bound form; however, it is missing from chain B of the substrate-bound form and native enzymatic state. This might be due to the formation of an H-bond between the scissile bond and the oxyanion hole residues during proteolysis. Moreover, the last C-terminal segment is highly flexible until the substrate attaches to the pocket and undergoes proteolysis. This loop is missing in the unblocked form, flexible in the substrate bound form, and static in C-terminal Trp-bound native state. Knowledge of the structure of the truncated unblocked alphavirus CP allows for a comprehensive analysis of capsid structures at different stages. The presence of glycerol in the active site of AVCP⌬2 where the P 1 residue Trp267 binds opens the possibility of designing glycerolbased alphavirus CP inhibitors. The reported structure highlights the previously unseen conformational changes and provides a foundation for structure-based design of antiviral compounds that will block the initial step of alphavirus structural polyprotein processing.
